Gaziosmanpasa University   Report issue

Academic/Hospital Phase 4
Founded: Tokat Turkey (1992)

Organization Overview

First Clinical Trial
2011
NCT01423838
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Alper Mengi | Department of Physical Medicine and Rehabilitation, Gaziosmanpasa Taksim Training and Research Hospital | Gaziosmanpasa Research and Education Hospital | Gaziosmanpasa Taksim Research and Education Hospital | Gaziosmanpasa University | Gaziosmanpasa University Medical School | Gaziosmanpasa Universty | Health Science University | Ozge Gokturk | Tokat Gaziosmanpasa University | Tuğba Karaman | University of Health Science,Gaziosmanpasa Training and Research Hospital

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Strabismus (Phase 4)

Trismus (Phase 4)

Urinary Bladder, Overactive (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 13
  • # of Trial APIs: 13